ENTITY
Consun Pharmaceutical

Consun Pharmaceutical (1681 HK)

59
Analysis
Health Care • China
Consun Pharmaceutical Group is a modern pharmaceutical enterprise engaged in the research, development, production, and marketing of modern Chinese medicines and medical imaging contrast mediums. It also manufactures and sells traditional Chinese medicines. Key products include Uremic Clearance Granule for kidney disease, Gadopentetate Dimeglumine Injection as a medical contrast medium, and Iron Dextran Oral Solution. The company was founded in 1997 and is headquartered in Guangzhou, China.
more
bullish•Haier Smart Home
•14 Nov 2022 23:26•Syndicated

Back in Hong Kong stocks

Early this year I was quite pessimistic on Hong Kong stocks. But since then the Hang Seng is down another 20% or so. A lot of stocks with 9-10%+...

Share
bullish•Consun Pharmaceutical
•16 Aug 2022 08:53

Consun Pharmaceutical (1681HK)- High-Priced Acquisition & Good Performance Show Big Upside Potential

Consun achieved amazing 2021 results and is undervalued. Wanbangde’s intention to acquire Consun at high price is a catalyst. Shares have big...

Logo
542 Views
Share
bullish•TK Group
•10 May 2022 08:27•Syndicated

Investing in HK Stocks

If you invest in Western markets this would be enough, but not in Asian markets where the trust factor is a lot lower, and where ownership is more...

Share
•30 Jan 2021 17:18

China Traditional Chinese Medicine Possible Privatisation

Sinopharm Hongkong, the controlling shareholder, is currently exploring a privatisation proposal. At the last close price, the downside risk is low...

Logo
707 Views
Share
bullish•Quantitative Analysis
•24 Apr 2020 11:51

HK Buyback League Table: Ronshine, China Star Ent, Consun

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
469 Views
Share
x